Infinity Pharmaceuticals reported $712K in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US USD 14.81B 229M
Amgen AMGN:US USD 6.84B 187M
AstraZeneca AZN:LN USD 10.98B 211M
Bristol Myers Squibb BMY:US USD 11.22B 669M
Eisai 4523:JP JPY 174.36B 9.9B
Eli Lilly And LLY:US USD 6.94B 453.6M
Gilead Sciences GILD:US USD 7.04B 782M
GlaxoSmithKline GSK:LN GBP 7.38B 453M
Infinity Pharmaceuticals INFI:US USD 712K 26K
Johnson & Johnson JNJ:US USD 23.71B 85M
Mirati Therapeutics MRTX:US USD 5.43M 69K
Novartis NOVN:VX USD 12.84B 243M
Pfizer PFE:US USD 24.29B 1.65B
Roche Holding ROG:VX CHF 32.3B 207M
Seattle Genetics SGEN:US USD 510.3M 12.8M
Tg Therapeutics TGTX:US USD 94K 500K
Vascular Biogenics VBLT:US USD 481K 417K
YTE INCY:US USD 823.3M 88.09M